Mudryk has been sidelined for nearly 18 months since he was provisionally suspended in December 2024 after failing a drug test while on international duty. He was charged in June 2025 and handed the maximum four-year ban by the FA after testing positive for the prohibited substance meldonium.

Since joining Chelsea FC for an initial fee of £88 million from Shakhtar Donetsk in January 2023, Mudryk has not played a competitive match. His absence from the field has raised questions about the impact on his career and Chelsea’s performance, as he scored 10 goals in 73 appearances.

Mudryk maintains his innocence, stating he has “never knowingly used any banned substances or broken any rules.” He described his situation as a “complete shock” and has been training with a private coach during his suspension. However, Chelsea has declined to comment on the ongoing case.

The FA has not disclosed specific details regarding the case, and officials have refrained from commenting further. As this appeal unfolds, Mudryk’s future hinges on the Court of Arbitration for Sport’s decision.

The implications of this case extend beyond Mudryk himself. It highlights ongoing discussions around doping regulations in football and how they are enforced by governing bodies like the FA. The outcome could influence how similar cases are handled in the future.

The next ruling from the Court of Arbitration for Sport is anticipated soon, which will determine if Mudryk can resume his career earlier than expected or if he must wait until December 2028.

The post Mudryk appeared first on cottenhamnews.